The BioFront Technologies line of anti-Zika virus monoclonal antibodies and ELISA kits have been referenced in numerous publications including Nature and Nature Medicine. Our Zika virus (ZIKV) reagents continue to produce reliable and trusted results for researchers leading the fight against this global issue.

Validated for use in Immunofluorescent, Western blot, and IP applications, BioFront's anti-ZIKV envelope monoclonal antibodies and anti-ZIKV NS1 monoclonal antibodies allow for highly sensitive and specific detection of all major ZIKV genotypes (MR766, FSS13025, PRVABC59) in various cell lines (Vero, C6-36, A549) without cross-reactivity to Dengue virus.